Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A 7 week multicenter, double-blind, randomized, placebo-controlled cross-over evaluation of the efficacy and safety of a modified-release oral dosage form of methylphenidate-HCl, Ritalin LA® (20 mg, q.d.) compared to Medikinet® ret. (20mg, q.d.) in children with attention deficit hyperactivity disorder (ADHD) aged 6 - 14 https://kusajili.com:443/Trial/6N_0kVRwrkiTfICBQ7sArQ%24a-7-week-multicenter-double-blind-randomized-placebo-controlled-cross-over-evaluation-of-the-efficacy-and-safety-of-a-modified-
I have read and accept the terms of use of the site and the Privacy Policy
Send your message